Royal Papworth Hospital strategic partnership with Philips aims to transform patient care
Guildford, UK–Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, and Royal Papworth Hospital have entered into an exciting strategic partnership to explore new healthcare innovations.
As part of the hospital’s commitment to working with industry to tackle major heart and lung conditions, the two organisations have agreed to team up on a number of projects that have the potential to transform patient care.
Stephen Posey, Chief Executive of Royal Papworth Hospital, and Neil Mesher, Chief Executive of Philips UK and Ireland, signed a Memorandum of Understanding at the Cambridge Biomedical Campus this month (June) which paves the way for the collaboration.
Among the projects already identified, the two organisations will be looking at speeding up heart attack diagnosis and treatment, and improving lung cancer screening.
Stephen Posey said; “This agreement brings together specialist clinicians from the UK’s leading heart and lung centre and experts from one of the world’s biggest technology companies to work on a range of treatment innovations. It is a truly exciting prospect.
History meets the future Since opening its doors a century ago this year, Royal Papworth Hospital has had a rich history of ‘world firsts’ and pioneering treatment. Our brand new hospital on the Cambridge Biomedical Campus – which includes five state-of-the-art theatres, five cath labs and two hybrid theatres – will help us to continue delivering the treatments of tomorrow to the patients of today.”
Neil Mesher said; “This is a truly exciting agreement that will help us find new approaches to tackling some of the big health challenges we face today. Philips is honoured to be a healthtech strategic partner to Royal Papworth and we’re eager to play our part in exploring how we can take improved patient care to new levels.”
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2017 sales of EUR 17.8 billion and employs approximately 75,000 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.
By clicking on the link, you will be leaving the official Royal Philips ("Philips") website. Any links to third-party websites that may appear on this site are provided only for your convenience and in no way represent any affiliation or endorsement of the information provided on those linked websites. Philips makes no representations or warranties of any kind with regard to any third-party websites or the information contained therein.